Lv6
2058 积分 2023-11-14 加入
Discovery of Two Novel Antiplatelet Clinical Candidates (BMS-986120 and BMS-986141) That Antagonize Protease-Activated Receptor 4
10天前
已完结
Discovery of 2,3-Dihydro[1,4]dioxino[2,3-g]benzofuran Derivatives as Protease Activated Receptor 4 (PAR4) Antagonists with Potent Antiplatelet Aggregation Activity and Low Bleeding Tendency
10天前
已完结
Synthesis and evaluation of novel and potent protease activated receptor 4 (PAR4) antagonists based on a quinazolin-4(3H)-one scaffold
10天前
已完结
Discovery of Potent and Selective Quinoxaline-Based Protease-Activated Receptor 4 (PAR4) Antagonists for the Prevention of Arterial Thrombosis
10天前
已完结
Discovery of quinazoline-benzothiazole derivatives as novel potent protease-activated receptor 4 antagonists with improved pharmacokinetics and low bleeding liability
10天前
已关闭
Resveratrol – A comprehensive review of recent advances in anticancer drug design and development
12天前
已完结
Novel [1,2,3]triazoles, [1,2,3]triazolo[4,5-d]Pyrimidines, and Some of Their Glycoside Derivatives: Synthesis and Molecular Modeling as Potential Apoptotic Antitumor Agents
15天前
已关闭
Protease activated receptor-4: ready to be part of the antithrombosis spectrum
15天前
已关闭
Embracing cancer complexity: Hallmarks of systemic disease
6个月前
已完结
The endoplasmic reticulum stress response in prostate cancer
8个月前
已完结
皖公网安备34019202002308
